Crowdfunding drug development: the state of play in oncology and rare diseases

Area of Science:

• Biomedical Research
• Oncology
• Rare Diseases
• Drug Development

Background:

• Traditional funding for early-stage research, particularly in oncology and rare diseases, faces significant competition.
• Innovators in drug development often require initial funding for proof-of-concept studies before seeking larger grants or investments.

Purpose of the Study:

• To analyze the role and effectiveness of crowdfunding in financing oncology and rare disease research.
• To assess crowdfunding as a supplementary funding source for early-stage research and drug development.

Main Methods:

• Descriptive analysis of 125 crowdfunding campaigns focused on oncology research (basic, drug discovery, clinical trials).
• Case study of five successful crowdfunding campaigns for ultrarare disease treatment development.

Main Results:

• Crowdfunding demonstrates viability for supporting early proof-of-concept research in oncology.
• Successful campaigns for ultrarare disease treatments indicate crowdfunding's potential in niche areas.
• Crowdfunding can enhance researchers' competitiveness for traditional grants and private investment.

Conclusions:

• Crowdfunding is a practical funding avenue for early-stage oncology and rare disease research.
• This model can serve as a valuable additional resource for early-stage drug development innovators.
• Successful crowdfunding campaigns can bridge funding gaps, enabling further research and development.